PET/CT and breast cancer subtypes

被引:5
作者
Gilardi, Laura [1 ]
Colleoni, Marco [2 ]
Paganelli, Giovanni [1 ]
机构
[1] European Inst Oncol, Div Nucl Med, I-20141 Milan, Italy
[2] European Inst Oncol, Div Med Senol, I-20141 Milan, Italy
关键词
RECOMMENDATIONS; CARCINOMA;
D O I
10.1007/s00259-013-2472-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1301 / 1303
页数:3
相关论文
共 32 条
[21]   Prognostic Significance of Progesterone Receptor-Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer [J].
Prat, Aleix ;
Cheang, Maggie Chon U. ;
Martin, Miguel ;
Parker, Joel S. ;
Carrasco, Eva ;
Caballero, Rosalia ;
Tyldesley, Scott ;
Gelmon, Karen ;
Bernard, Philip S. ;
Nielsen, Torsten O. ;
Perou, Charles M. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) :203-209
[22]   Practical implications of gene-expression-based assays for breast oncologists [J].
Prat, Aleix ;
Ellis, Matthew J. ;
Perou, Charles M. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (01) :48-57
[23]   Breast cancer molecular subtypes respond differently to preoperative chemotherapy [J].
Rouzier, R ;
Perou, CM ;
Symmans, WF ;
Ibrahim, N ;
Cristofanilli, M ;
Anderson, K ;
Hess, KR ;
Stec, J ;
Ayers, M ;
Wagner, P ;
Morandi, P ;
Fan, C ;
Rabiul, I ;
Ross, JS ;
Hortobagyi, GN ;
Pusztai, L .
CLINICAL CANCER RESEARCH, 2005, 11 (16) :5678-5685
[24]   Increased FDG uptake in breast cancer is associated with prognostic factors [J].
Sanli, Yasemin ;
Kuyumcu, Serkan ;
Ozkan, Zeynep Gozde ;
Isik, Goknur ;
Karanlik, Hasan ;
Guzelbey, Burcu ;
Turkmen, Cuneyt ;
Ozel, Sevda ;
Yavuz, Ekrem ;
Mudun, Ayse .
ANNALS OF NUCLEAR MEDICINE, 2012, 26 (04) :345-350
[25]   Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? [J].
Simmons, C. ;
Miller, N. ;
Geddie, W. ;
Gianfelice, D. ;
Oldfield, M. ;
Dranitsaris, G. ;
Clemons, M. J. .
ANNALS OF ONCOLOGY, 2009, 20 (09) :1499-1504
[26]   Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications [J].
Sorlie, T ;
Perou, CM ;
Tibshirani, R ;
Aas, T ;
Geisler, S ;
Johnsen, H ;
Hastie, T ;
Eisen, MB ;
van de Rijn, M ;
Jeffrey, SS ;
Thorsen, T ;
Quist, H ;
Matese, JC ;
Brown, PO ;
Botstein, D ;
Lonning, PE ;
Borresen-Dale, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) :10869-10874
[27]   18F-fluoroestradiol [J].
Sundararajan, Lavanya ;
Linden, Hannah M. ;
Link, Jeanne M. ;
Krohn, Kenneth A. ;
Mankoff, David A. .
SEMINARS IN NUCLEAR MEDICINE, 2007, 37 (06) :470-476
[28]   Degree of Tumor FDG Uptake Correlates with Proliferation Index in Triple Negative Breast Cancer [J].
Tchou, Julia ;
Sonnad, Seema S. ;
Bergey, Meredith R. ;
Basu, Sandip ;
Tomaszewski, John ;
Alavi, Abass ;
Schnall, Mitchell .
MOLECULAR IMAGING AND BIOLOGY, 2010, 12 (06) :657-662
[29]   Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer [J].
Ueda, Shigeto ;
Tsuda, Hitoshi ;
Asakawa, Hideki ;
Shigekawa, Takashi ;
Fukatsu, Kazuhiko ;
Kondo, Nobuo ;
Yamamoto, Mikio ;
Hama, Yukihiro ;
Tamura, Katsumi ;
Ishida, Jiro ;
Abe, Yoshiyuki ;
Mochizuki, Hidetaka .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (04) :250-258
[30]   Integrating molecular profiling, histological type and other variables: Defining the fingerprint of responsiveness to treatment [J].
Viale, Giuseppe .
BREAST, 2009, 18 :S32-S36